Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21644 | 354 | 35.7 | 81% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CYP1A2 | Author keyword | 19 | 18% | 27% | 97 |
2 | CAFFEINE METABOLISM | Author keyword | 9 | 45% | 4% | 15 |
3 | CYP1A2 ACTIVITY | Author keyword | 5 | 55% | 2% | 6 |
4 | 1 METHYLXANTHINE | Author keyword | 4 | 50% | 2% | 6 |
5 | CAFFEINE OXIDATION | Author keyword | 3 | 100% | 1% | 3 |
6 | CYP1A2 POLYMORPHISM | Author keyword | 3 | 100% | 1% | 3 |
7 | PARAXANTHINE | Author keyword | 3 | 24% | 3% | 11 |
8 | CYTOCHROME P 450 ACTIVITY | Author keyword | 3 | 50% | 1% | 4 |
9 | 1 METHYLURIC ACID | Author keyword | 2 | 50% | 1% | 3 |
10 | CYTOCHROME P450 1A2 | Author keyword | 2 | 19% | 3% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYP1A2 | 19 | 18% | 27% | 97 | Search CYP1A2 | Search CYP1A2 |
2 | CAFFEINE METABOLISM | 9 | 45% | 4% | 15 | Search CAFFEINE+METABOLISM | Search CAFFEINE+METABOLISM |
3 | CYP1A2 ACTIVITY | 5 | 55% | 2% | 6 | Search CYP1A2+ACTIVITY | Search CYP1A2+ACTIVITY |
4 | 1 METHYLXANTHINE | 4 | 50% | 2% | 6 | Search 1+METHYLXANTHINE | Search 1+METHYLXANTHINE |
5 | CAFFEINE OXIDATION | 3 | 100% | 1% | 3 | Search CAFFEINE+OXIDATION | Search CAFFEINE+OXIDATION |
6 | CYP1A2 POLYMORPHISM | 3 | 100% | 1% | 3 | Search CYP1A2+POLYMORPHISM | Search CYP1A2+POLYMORPHISM |
7 | PARAXANTHINE | 3 | 24% | 3% | 11 | Search PARAXANTHINE | Search PARAXANTHINE |
8 | CYTOCHROME P 450 ACTIVITY | 3 | 50% | 1% | 4 | Search CYTOCHROME+P+450+ACTIVITY | Search CYTOCHROME+P+450+ACTIVITY |
9 | 1 METHYLURIC ACID | 2 | 50% | 1% | 3 | Search 1+METHYLURIC+ACID | Search 1+METHYLURIC+ACID |
10 | CYTOCHROME P450 1A2 | 2 | 19% | 3% | 9 | Search CYTOCHROME+P450+1A2 | Search CYTOCHROME+P450+1A2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CAFFEINE URINARY METABOLITES | 12 | 44% | 6% | 20 |
2 | EXTRACTIONLESS METHOD | 8 | 100% | 1% | 5 |
3 | CYP1A2 | 7 | 15% | 12% | 44 |
4 | PARAXANTHINE | 7 | 29% | 5% | 19 |
5 | CAFFEINE METABOLITE RATIOS | 6 | 71% | 1% | 5 |
6 | CYTOCHROME P4501A2 | 6 | 23% | 6% | 23 |
7 | METABOLITE RATIOS | 6 | 40% | 3% | 12 |
8 | C 8 HYDROXYLATION | 6 | 100% | 1% | 4 |
9 | PARTIAL CLEARANCES | 4 | 75% | 1% | 3 |
10 | CAFFEINE METABOLISM | 4 | 20% | 5% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms | 2008 | 73 | 128 | 37% |
Insights into the Substrate Specificity, Inhibitors, Regulation, and Polymorphisms and the Clinical Impact of Human Cytochrome P450 1A2 | 2009 | 55 | 93 | 32% |
Measurement of CYP1A2 Activity: A Focus on Caffeine as a Probe | 2012 | 13 | 120 | 49% |
Assessment of CYP1A2 activity in clinical practice: Why, how, and when? | 2005 | 96 | 108 | 24% |
Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat | 2008 | 28 | 61 | 41% |
Caffeine Metabolic Ratios for the In Vivo Evaluation of CYP1A2, N-acetyltransferase 2, Xanthine Oxidase and CYP2A6 Enzymatic Activities | 2009 | 8 | 76 | 58% |
Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia | 2013 | 2 | 179 | 38% |
Effects of dietary broccoli on human in vivo caffeine metabolism: A pilot study on a group of Jordanian volunteers | 2007 | 15 | 37 | 46% |
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2 | 2010 | 70 | 629 | 12% |
Assays for CYP1A2 by testing in vivo metabolism of caffeine in humans | 1996 | 17 | 15 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METAB BIOPHYS PL PHARMACOL | 1 | 33% | 0.8% | 3 |
2 | ABT ERNAHRUNGSTOXIKOL | 1 | 50% | 0.3% | 1 |
3 | E SIBERIAN HUMAN ECOL | 1 | 50% | 0.3% | 1 |
4 | GRP PHARMACEUT ANAL | 1 | 50% | 0.3% | 1 |
5 | HUNAN MED UNIV | 1 | 50% | 0.3% | 1 |
6 | INHA IST MED SCI | 1 | 50% | 0.3% | 1 |
7 | MED BK 21 PROJECT | 1 | 50% | 0.3% | 1 |
8 | SECT HYG OCCUPAT MED | 1 | 20% | 0.8% | 3 |
9 | PEDIAT CLIN PHARMACOL EXPT THER EUT | 1 | 22% | 0.6% | 2 |
10 | BANTING 2201C | 0 | 33% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000241807 | PERINATAL NUTR METAB//SECT DEV ENDOCRINOL BIOLYALE CHILD HLTH CT//XENOBIOTIC AGENTS |
2 | 0.0000240864 | ARYLAMINE N ACETYLTRANSFERASE//NAT2//N ACETYLTRANSFERASE |
3 | 0.0000193090 | 9 HYDROXYRISPERIDONE//NORCLOZAPINE//PALIPERIDONE |
4 | 0.0000191521 | MONOETHYLGLYCINEXYLIDIDE//MEGX//C 13 METHACETIN |
5 | 0.0000147448 | ENERGY DRINKS//CAFFEINE//ENERGY DRINK |
6 | 0.0000146342 | CYP3A//COCKTAIL//MECHANISM BASED INHIBITION |
7 | 0.0000126070 | CAS 58 55 9//ABT BIOPHARM PHARMAKOKINETIK//BRONCHORETARD R |
8 | 0.0000125860 | TRIMETHADIONE//ZAKLAD CHEM FIZJOL//ZAKLAD CHEM FIZJOLOGICZNEJ |
9 | 0.0000115788 | PAULLINIA CUPANA//GUARANA//PTYCHOPETALUM OLACOIDES |
10 | 0.0000114846 | AVITRIPTAN//ENVIRONM INJURY EPIDEMIOL TOXICOL UNIT//HOMICIDE PREVENTION |